Fig. 11.1
From: Biomarkers and Precision Medicine in Oncology Practice and Clinical Trials
Average patient response versus the value of a pretreatment personalized healthcare biomarker (PHC) in a single arm trial. While there appears to be a correlation between response and biomarker value, it is not possible to determine whether the biomarker is prognostic or predictive without a control group for comparison